Annual Meeting of the American Radium Society (ARS)

An unmet clinical need in breast cancer (BC) management is the identification of which patients will respond to radiation therapy (RT). We hypothesized that the integration of post-RT clonogenic survival data with gene expression data across a large spectrum of BC cell lines would generate a BC-specific RT sensitivity signature predictive for RT response in BC patients and allow identification of patients with tumors refractive to conventional therapy.

Using repeated measures analyses, we analyzed the data from the originally published N06C4 prospective trial and present here the CTCAE-based temporal profile of acute skin toxicities, when time factor was considered.

We aim to examine the difference between outcomes in young women (aged < 40 y) treated with breast-conserving therapy consisting of partial breast surgery and radiation therapy vs mastectomy.

The goal of this study is to use a national database to examine how practice patterns changed prior to versus after publication of the ASTRO accelerated partial breast irradiation guideline.

The goal of this study is to assess locoregional outcomes associated with breast cancer subtype in stage III locally advanced breast cancer patients after surgery, radiation therapy, and modern systemic therapy.

We examined whether presenting stage at time of breast cancer diagnosis has changed over time in Florida and whether there is variation in this change with respect to race, ethnicity, and socioeconomic status.